Literature DB >> 29859014

Medical cannabis: aligning use to evidence-based medicine approach.

Lihi Bar-Lev Schleider1, Ran Abuhasira1, Victor Novack1.   

Abstract

During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicine. With respect to cannabis Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds. This opinion paper discusses selected studies into the safety and effects of cannabis derived products.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29859014      PMCID: PMC6177696          DOI: 10.1111/bcp.13657

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  34 in total

1.  Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Christian A Kell; Ulrike Nöth; Johannes Vermehren; Jochen Kaiser; Ralf Deichmann; Jörn Lötsch
Journal:  Neuropsychopharmacology       Date:  2015-10-30       Impact factor: 7.853

2.  Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.

Authors:  Timna Naftali; Refael Mechulam; Amir Marii; Gila Gabay; Asaf Stein; Miriam Bronshtain; Ido Laish; Fabiana Benjaminov; Fred M Konikoff
Journal:  Dig Dis Sci       Date:  2017-03-27       Impact factor: 3.199

3.  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Authors:  Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

4.  Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease.

Authors:  A Shohet; A Khlebtovsky; N Roizen; Y Roditi; R Djaldetti
Journal:  Eur J Pain       Date:  2016-10-10       Impact factor: 3.931

5.  Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana.

Authors:  Daniel Feingold; Silviu Brill; Itay Goor-Aryeh; Yael Delayahu; Shaul Lev-Ran
Journal:  J Affect Disord       Date:  2017-04-21       Impact factor: 4.839

6.  Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS).

Authors:  Mark A Ware; Tongtong Wang; Stan Shapiro; Jean-Paul Collet
Journal:  J Pain       Date:  2015-09-16       Impact factor: 5.820

7.  Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder.

Authors:  Pablo Roitman; Raphael Mechoulam; Rena Cooper-Kazaz; Arieh Shalev
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

8.  Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer.

Authors:  Lihi Bar-Lev Schleider; Raphael Mechoulam; Violeta Lederman; Mario Hilou; Ori Lencovsky; Oded Betzalel; Liat Shbiro; Victor Novack
Journal:  Eur J Intern Med       Date:  2018-03       Impact factor: 4.487

9.  The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study.

Authors:  Simon Haroutounian; Yael Ratz; Yehuda Ginosar; Karina Furmanov; Fayez Saifi; Ronit Meidan; Elyad Davidson
Journal:  Clin J Pain       Date:  2016-12       Impact factor: 3.442

10.  The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology.

Authors:  Margherita Russo; Vincenzo Dattola; Anna Lisa Logiudice; Rosella Ciurleo; Edoardo Sessa; Rosaria De Luca; Placido Bramanti; Alessia Bramanti; Antonino Naro; Rocco Salvatore Calabrò
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

View more
  8 in total

1.  Care and concern with cannabinoids used therapeutically.

Authors:  Jennifer H Martin; Noel Cranswick
Journal:  Br J Clin Pharmacol       Date:  2018-08-22       Impact factor: 4.335

Review 2.  Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.

Authors:  Barbara Stella; Francesca Baratta; Carlo Della Pepa; Silvia Arpicco; Daniela Gastaldi; Franco Dosio
Journal:  Drugs       Date:  2021-09-04       Impact factor: 9.546

Review 3.  Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes.

Authors:  Jamie O Lo; Jason C Hedges; Guillermina Girardi
Journal:  Am J Obstet Gynecol       Date:  2022-05-31       Impact factor: 10.693

4.  Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations.

Authors:  Arthur Cassa Macedo; André Oliveira Vilela de Faria; Isabella Bizzi; Fabrício A Moreira; Alessandro Colasanti; Pietro Ghezzi
Journal:  J Cannabis Res       Date:  2022-07-11

5.  Medical Cannabis for Older Patients-Treatment Protocol and Initial Results.

Authors:  Ran Abuhasira; Addie Ron; Inbal Sikorin; Victor Novack
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

6.  Full-Spectrum Cannabis Extract Microdepots Support Controlled Release of Multiple Phytocannabinoids for Extended Therapeutic Effect.

Authors:  Almog Uziel; Anat Gelfand; Keren Amsalem; Paula Berman; Gil M Lewitus; David Meiri; Dan Y Lewitus
Journal:  ACS Appl Mater Interfaces       Date:  2020-05-15       Impact factor: 9.229

7.  Phytocannabinoids Profile in Medicinal Cannabis Oils: The Impact of Plant Varieties and Preparation Methods.

Authors:  Michele Dei Cas; Eleonora Casagni; Antonella Casiraghi; Paola Minghetti; Diego Maria Michele Fornasari; Francesca Ferri; Sebastiano Arnoldi; Veniero Gambaro; Gabriella Roda
Journal:  Front Pharmacol       Date:  2020-11-13       Impact factor: 5.810

Review 8.  Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.

Authors:  Muhammad Yousaf; Dennis Chang; Yang Liu; Tianqing Liu; Xian Zhou
Journal:  Molecules       Date:  2022-08-04       Impact factor: 4.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.